Related Experiment Video
Updated: Apr 28, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
20.2K
Risperidone for non-cognitive symptoms of dementia
1Department of Psychiatry, University of Vienna, Austria.
International Journal of Psychiatry in Clinical Practice
|June 14, 2014
Summary
This case study highlights successful treatment of non-cognitive symptoms in an elderly dementia patient using risperidone. The atypical antipsychotic effectively resolved behavioral issues and side effects, improving patient care.
Area of Science:
- Geriatric Psychiatry
- Neuroscience
- Clinical Pharmacology
Background:
- Elderly patients with dementia often exhibit challenging non-cognitive symptoms.
- Conventional psychotropic treatments can be ineffective and lead to adverse effects.
- Managing behavioral disturbances in dementia requires careful consideration of medication.
Purpose of the Study:
- To report a case of successful management of non-cognitive symptoms in an elderly dementia patient.
- To evaluate the efficacy and tolerability of risperidone in this population.
- To emphasize the need for specialized psychopharmacological training for physicians treating elderly patients.
Main Methods:
- A case report of a 95-year-old male with dementia and non-cognitive symptoms.
- Initial treatment with polycyclic antidepressants and neuroleptics proved unsuccessful.
- Switching to risperidone for symptom management.
Main Results:
- Risperidone administration led to significant reduction in non-cognitive symptoms such as aggression and restlessness.
- Extrapyramidal side effects and sedation were markedly reduced.
- Complete resolution of all non-cognitive symptoms and side effects was achieved with risperidone.
Conclusions:
- Risperidone can be an effective treatment for non-cognitive symptoms in elderly dementia patients.
- This case underscores the importance of appropriate psychopharmacological training for non-psychiatric physicians.
- Individualized treatment approaches are crucial for managing complex geriatric psychiatric conditions.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699
01:28Psychosis and Antipsychotic Drugs: Overview
1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
01:30Negative and Cognitive Symptoms of Schizophrenia
1.1K
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
1.1K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:21Antipsychotic Drugs: Typical and Atypical Agents
1.3K
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
1.3K